DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/f4grlw/lymphoma_drug) has announced the addition of the "Lymphoma Drug Pathway Analyzer 2013" report to their offering. There are today at least 317 targeted molecular therapies known to affect more than 228 specific intracellular signaling pathways for the...
More...
